The Mexican HIV/AIDS surveillance system: 1986–2001

Minichiello, Shanthi Noriega; Magis, Carlos; Uribe, Patricia Martínez; Anaya, Luis; Bertozzi, Stefano

doi:10.1097/00002030-200212003-00003

Cited by 13 publications

(24 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…12 The Mexican government's Centro Nacional para la Prevención y el Control del VIH/SIDA (CENSIDA) estimates that there are currently 150,000 people infected with HIV throughout Mexico, which includes 99,000 (66%) MSM, 38,600 (26%) adult heterosexuals, 3300 (2.2%) female sex workers (FSWs), 1700 (1.1%) male sex workers (MSWs), 2900 (1.9%) IDUs, and 4500 (3%) incarcerated persons. 11 In Mexico, national HIV prevalence estimates for 2000 were generated by CENSIDA for the cohort of persons aged 15 to 49 years. 12a HIV prevalence has been highest among the high-risk subpopulations of MSM and IDUs, with a relatively low HIV prevalence of 0.29% among the general population.…”

Section: Epidemiology Of Hiv/aids In Mexicomentioning

confidence: 99%

Section: Epidemiology Of Hiv/aids In Mexicomentioning

confidence: 99%

“…11 Currently, AIDS is the 16th leading cause of death in Mexico, with 4.3 deaths per 100,000 population. 11 The most affected cohort, those aged 24 to 35 years, accounts for 41.6% of all reported cases. 11 Within this age cohort, AIDS is the fourth leading cause of death among men and the seventh among women.…”

Section: Epidemiology Of Hiv/aids In Mexicomentioning

confidence: 99%

“…11 The most affected cohort, those aged 24 to 35 years, accounts for 41.6% of all reported cases. 11 Within this age cohort, AIDS is the fourth leading cause of death among men and the seventh among women. 11 Given the concentrated nature of Mexico's HIV epidemic, most cases are associated with the MSM, IDU, FSW, and youth risk groups.…”

Section: Epidemiology Of Hiv/aids In Mexicomentioning

confidence: 99%

“…11 Within this age cohort, AIDS is the fourth leading cause of death among men and the seventh among women. 11 Given the concentrated nature of Mexico's HIV epidemic, most cases are associated with the MSM, IDU, FSW, and youth risk groups. 11 A noteworthy trend is the emergence of the AIDS epidemic within rural communities throughout Mexico.…”

Section: Epidemiology Of Hiv/aids In Mexicomentioning

confidence: 99%

See 4 more Smart Citations

The Epidemiology of HIV Among Mexican Migrants and Recent Immigrants in California and Mexico

Sanchez¹,

Lemp²,

Magis-Rodríguez³

et al. 2004

JAIDS Journal of Acquired Immune Deficiency Syndromes

View full text Add to dashboard Cite

For Mexican migrants and recent immigrants, the impact of migration from Mexico to California has the potential to lead to an increased risk for HIV infection. Until recently, the prevalence of HIV in Mexico and among Mexican migrants in California appeared to be stable and relatively low. Recent studies have raised new concerns, however, that the HIV epidemic may expand more aggressively among this population in the coming years. Unfortunately, the insufficient amount of data available within recent years makes it difficult to fully assess the potential for rapid spread of the HIV epidemic among this population. Consequently, there is a critical need for an ongoing binational surveillance system to assess prevalence and trends in HIV/STD/TB disease and related risk behaviors among this population both in Calfornia and within this population's states of origin in Mexico. This enhanced epidemiologic surveillance system should provide improved data on the subpopulations at the highest risk for HIV/STD/TB, such as men who have sex with men, and should provide the opportunity to evaluate the impact of migration on the transmission dynamics, risk behaviors, and determinants of behavior on each side of the border. It is essential that this potential threat be assessed and that intervention programs are developed and implemented to combat this possible escalation in the HIV epidemic.

show abstract

Section: Epidemiology Of Hiv/aids In Mexicomentioning

confidence: 99%

Section: Epidemiology Of Hiv/aids In Mexicomentioning

confidence: 99%

Section: Epidemiology Of Hiv/aids In Mexicomentioning

confidence: 99%

Section: Epidemiology Of Hiv/aids In Mexicomentioning

confidence: 99%

Section: Epidemiology Of Hiv/aids In Mexicomentioning

confidence: 99%

See 3 more Smart Citations

The Epidemiology of HIV Among Mexican Migrants and Recent Immigrants in California and Mexico

Sanchez¹,

Lemp²,

Magis-Rodríguez³

et al. 2004

JAIDS Journal of Acquired Immune Deficiency Syndromes

View full text Add to dashboard Cite

show abstract

HIV-related lipodystrophy and facial lipoatrophy: The role of Restylane SubQ in reversing facial wasting

Strand¹,

Wolters

2006

Aesthetic Surgery Journal

View full text Add to dashboard Cite

HIV-associated lipodystrophy syndrome affects approximately 50% of HIV-positive patients, particularly those receiving antiretroviral therapy based on nucleoside reverse transcriptase inhibitors and protease inhibitors. Growing evidence suggests that certain antiretroviral drugs may precipitate or exacerbate lipoatrophy and associated metabolic abnormalities, and this is an important consideration when selecting appropriate treatment regimens. However, because of problems of cross-resistance among antiretroviral drug classes and other treatment-related toxicities, it is likely that, at some stage, the HIV-infected patient will have to take drugs that confer a risk of development of lipodystrophy syndrome. Combination therapy for HIV, known as highly active antiretroviral therapy (HAART), has dramatically altered the prognosis for the HIV-infected individual. With optimal use of HAART, which includes regular monitoring of viral load, viral resistance, and compliance with medication, HIV infection has changed from being a fatal disease to a lifelong infection. However, HAART-related lipodystrophy syndrome, and especially facial lipoatrophy, is of great concern for patients and physicians involved in HIV care. For the patient, facial lipoatrophy is a major stigma that affects self-esteem and social interaction, and in some cases, it is a cause of noncompliance with HAART. Accordingly, many treatment-experienced HIV patients are requesting, and being treated with, various dermal fillers for cosmetic correction of facial lipoatrophy. Prior to the introduction of HAART, when life expectancy for the HIV-infected individual was severely limited, permanent fillers were widely used for this purpose. Because these products remain in situ indefinitely and the facial soft tissues change over time, the permanent fillers are no longer a satisfactory treatment option. Now that HIV infection has been transformed into a chronic but not necessarily life-threatening disease, there is an urgent need for a safe, biodegradable, and biocompatible alternative dermal filler for treating HIV-associated facial lipoatrophy.

show abstract

Historical trends in the production and consumption of illicit drugs in Mexico: Implications for the prevention of blood borne infections

Bucardo

Brouwer

Magis-Rodríguez³

et al. 2005

Drug and Alcohol Dependence

153

128

View full text Add to dashboard Cite

Mexico has cultivated opium poppy since before the 1900's and has been an important transit route for South American cocaine for decades. However, only recently has drug use, particularly injection drug use, been documented as an important problem. Heroin is the most common drug used by Mexican injection drug users (IDUs). Increased cultivation of opium poppy in some Mexican states, lower prices for black tar heroin and increased security at U.S.-Mexican border crossings may be contributing factors to heroin use, especially in border cities. Risky practices among IDUs, including needle sharing and shooting gallery attendance are common, whereas perceived risk for acquiring blood borne infections is low. Although reported AIDS cases attributed to IDU in Mexico have been low, data from sentinel populations, such as pregnant women in the Mexican-U.S. border city of Tijuana, suggest an increase in HIV prevalence associated with drug use. Given widespread risk behaviors and rising numbers of blood borne infections among IDUs in Mexican-U.S. border cities, there is an urgent need for increased disease surveillance and culturally appropriate interventions to prevent potential epidemics of blood borne infections. We review available literature on the history of opium production in Mexico, recent trends in drug use and its implications, and the Mexican response, with special emphasis on the border cities of Ciudad Juarez and Tijuana.

show abstract

The Mexican HIV/AIDS surveillance system: 1986–2001

Cited by 13 publications

References 2 publications

The Epidemiology of HIV Among Mexican Migrants and Recent Immigrants in California and Mexico

The Epidemiology of HIV Among Mexican Migrants and Recent Immigrants in California and Mexico

HIV-related lipodystrophy and facial lipoatrophy: The role of Restylane SubQ in reversing facial wasting

Historical trends in the production and consumption of illicit drugs in Mexico: Implications for the prevention of blood borne infections

Contact Info

Product

Resources

About